AarogyaAI | AarogyaAI leverages the power of genomics and artificial intelligence to diagnose antimicrobial resistance in infectious pathogens, infecting patients at the point of care.
Ai2Ai Oy | PALL0 by Ai2Ai is a sensor-packed interactive ball with AI and unlimited apps. The product boosts physical and social activities for wellness seekers and reduces screen time.
Auxcuro Inc | Auxcuro provides technical solutions for healthcare clinicians by integrating care delivery information in real-time. The company’s technical platform is an intuitive, customisable, predictive smart data integration repository that supports Frontline Healthcare Workers.
Cardiolyse | Cardiolyse provides a chronic and post-discharge cardiovascular disease patient monitoring platform with medical-grade AI heart health analytics (CE class 2a, 19 arrhythmias) that enables remote vital sign monitoring and personalised patient reports for early diagnostics and better care.
ClickPET | ClickPET offers technical solutions for simplifying the production of cancer type specific biomolecule-based radiopharmaceuticals for positron emission tomography (PET) for aiding patient selection, cancer staging and disease follow-up by diagnostic imaging. The company’s technology allows the speeding-up of new radiotracer development to novel targets facilitating the discovery of new diagnostic methods for personalized medicine.
CorFlux | CorFlux aims to be the world’s leading analysing software for estimating the risk of aortic aneurysm rupture. The current clinical method does not take into account other influencing elements than the aortic diameter in the risk evaluation. However, a high number of aortic ruptures appear before the diameter reaches the limit for surgery. CorFlux decision-making support allows physicians to identify high risk aneurysm patients more easily, leading to life savings.
HATO Medical Technologies | HATO Medical Technologies empowers healthcare professionals to make prompt decisions, accurate triage, correct referrals, and save lives and valuable resources by getting it right the first time. The company utilises AI to enhance the accuracy and efficiency of electrocardiogram (ECG) interpretation. By providing innovative solutions, HATO aims to support healthcare professionals, especially those without specialised cardiology expertise, in diagnosing and treating cardiovascular diseases more effectively.
MEDIVERSE | Mediverse functions as a crucial component of the conventional healthcare system, operating as a telemedicine platform that incorporates advanced technology and intelligent biosensors. As a result, patients can receive remote medical consultations, diagnoses, and treatments in a timely manner, irrespective of their location.
R2therapies Oy | R2therapies Oy has discovered a novel and scientifically surprising blood-based biomarker to identify people at risk of developing dementia. The company aims to develop an in-vitro diagnostic method compatible with primary healthcare for dementia-risk screening.
SIR Analytics | SIR Analytics brings 21st-century technology to help blind people around the globe. Using the company’s smart cane, blind and visually impaired people can independently move around without unnecessary risks of injuries or getting lost.
Up to 3 years of customised mentoring and advice